SPECTRACURE
SpectraCure provides photoreactive drugs for treatment of internal cancer tumours.
SPECTRACURE
Industry:
Health Care Hospital Medical Device
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.spectracure.com
Total Employee:
11+
Status:
Active
Contact:
+46 46 162070
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Google Maps Cloudflare Hosting
Similar Organizations
Cardionovum
Cardionovum provides cardiovascular medical solutions for the treatment of coronary and peripheral artery disease.
MelCure
MelCure develops and manufactures drugs for treatment of Metastatic melanoma cancer.
TeMeCo
TeMeCo provides telemonitoring solutions for healthcare sectors.
Official Site Inspections
http://www.spectracure.com Semrush global rank: 11.52 M Semrush visits lastest month: 156
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "SpectraCure"
SpectraCure | Utvecklar framtidens cancerbehandling
SpectraCure is a medical technology company focused on developing a new treatment system for localised prostate cancer. Our goal is to offer a highly precise focal treatment, which has the potential to provide a more …See details»
SpectraCure | Utvecklar framtidens cancerbehandling
Nov 14, 2024 SpectraCure utvecklar ett behandlingsystem för eliminering av inre solida cancertumörer. Vi fokuserar initialt på återfallscancer i prostata, med en förhoppning att i …See details»
Medicintekniskt bolag - utvecklar framtidens …
May 18, 2021 SpectraCure is developing the future systems for the treatment of internal solid cancer tumours. The goal of the proprietary and patented treatment system is to eliminate deep-seated cancer tumours and prolong the survival of …See details»
SpectraCure - Crunchbase Company Profile & Funding
SpectraCure is located in Lund, Skane Lan, Sweden. Who are SpectraCure 's competitors? Alternatives and possible competitors to SpectraCure may include Cardionovum , Cystotech , …See details»
SpectraCure Company Profile - Office Locations, Competitors
Oct 22, 2024 SpectraCure is a company that provides treatment of internal solid cancer tumors. It develops software with an interstitial photodynamic therapy system. The company also …See details»
SpectraCure Company Profile 2024: Stock Performance & Earnings …
What is SpectraCure’s annual earnings per share (EPS)? SpectraCure’s EPS for 12 months was -$0.02. Data Transparency. Meet our data hygiene team. Discover how our experts ensure …See details»
SpectraCure - Products, Competitors, Financials, Employees ...
SpectraCure : Meet SpectraCure's board member, Homer Pien! Oct 31, 2023. October 31, 2023 at 10:58 am EDT Share Homer Pien has an impressive background with experience in leading …See details»
Governance SpectraCure AB - MarketScreener.com
Dec 31, 2016 SpectraCure AB (publ) is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company specializes in cancer treatment technology. The …See details»
SpectraCure: from university start-up to public company
SpectraCure: from university start-up to public company. Johannes Swartling, CTO. Kista, 17 October 2017 • Founded 2003 as a start-up from Lund University, Division of Atomic Physics • …See details»
Board - SpectraCure
Shares in SpectraCure AB: 200 000 shares (incl. related) Katarina Svanberg is M.D., PhD and has for a long time been a consultant and adjunct professor of oncology at Lund University. ... Society for Optics and Photonics – the …See details»
SpectraCure - Overview, News & Similar companies - ZoomInfo
Jun 7, 2022 View SpectraCure (www.spectracure.com) location in Skane, Sweden , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
SpectraCure AB Company Overview, Contact Details
SpectraCure AB. Medical Equipment Manufacturing Sweden 11-50 Employees. SpectraCure har sin bakgrund i Lunds universitets avdelningar för medicinska lasertillämpningar och fysik. …See details»
Wider Range of Prospective Patients in the UK, Canada and the US …
Jun 18, 2020 SpectraCure was founded in 2003 as a spin off from Lund University and LTH Faculty of Engineering in Sweden. The company focuses on cancer treatments with medical …See details»
SpectraCure : Status update regarding clinical studies for the ...
Mar 5, 2021 SpectraCure AB (publ), CEO, Masoud Khayyami, telephone: +46(0) 70 815 21 90. SpectraCure was founded in 2003 as a spin off from Lund University and LTH Faculty of …See details»
SpectraCure in Brief
SpectraCure’s Solution - Consisting of Three Components. 11 The patient is given verteporfin, which is a drug that makes the tissue sensitive to light. 1. Needles are inserted into the tumour …See details»
SpectraCure
Dec 1, 2024 SpectraCure är ett medicinteknikbolag som fokuserar på att utveckla ett nytt medicintekniskt behandlingssystem för lokaliserad prostatacancer. Målet är att erbjuda en …See details»
SpectraCure takes the next step in the work with the new clinical …
Feb 23, 2024 SpectraCure is developing a treatment system for the elimination of internal solid cancer tumors. We are initially focusing on recurrent prostate cancer, with the hope of being …See details»
Reinforcements in SpectraCure’s organization
Feb 24, 2020 Today we are welcoming Johan Glindre to SpectraCure. Johan Glindre will be working as a Clinical Project Leader and has a solid background in clinical studies, project …See details»
Uppdatering från SpectraCures strategimöte samt de senast ...
Oct 1, 2024 SpectraCure har haft strategimöte med styrelse och ledning som primärt syftade till fortsattplanering av de kliniska studierna för återfall av prostatacancer. Ett stort fokus på mötet …See details»
Press releases - SpectraCure
2023-11-16 15:30 SpectraCure has decided to seek approval for a clinical study of primary prostate cancer Regulatory MAR. 2023-10-06 14:30 SpectraCure strengthens presence …See details»